Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2004;57:1151-1155; doi:10.1136/jcp.2003.015818
Copyright © 2004 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2004;57:1151-1155
© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists

ORIGINAL ARTICLE

Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation

A Juuti1, S Nordling2, J Louhimo1, J Lundin1 and C Haglund1

1 Department of Surgery, Helsinki University Central Hospital, Helsinki, 00029 HUS, Finland
2 Department of Pathology, University of Helsinki and Helsinki University Central Hospital

Correspondence to:
Correspondence to:
Dr C Haglund
Department of Surgery, Helsinki University Central Hospital, PO Box 340, 00029 HUS, Finland; caj.haglund{at}hus.fi

Background: Tenascin C is a large, hexameric, extracellular matrix protein that is present during embryonic development but essentially absent in adult tissues. It is involved in remodelling processes, such as wound healing and tumour development. Tissue expression of tenascin C correlates with prognosis in colorectal, cervical, and breast cancer and in carcinoma of the papilla of Vater.

Aim: To study the expression of tenascin C in pancreatic cancer and to compare the staining results with the patients’ clinicopathological data.

Material and methods: Formalin fixed, paraffin wax embedded specimens from 146 patients with pancreatic adenocarcinoma were stained with an anti-tenascin C monoclonal antibody.

Results: Tenascin C immunoreactivity was seen in most samples of pancreatic carcinoma: staining was weak in 72 (49%), moderate in 52 (36%), strong in 10 (7%), and negative in 12 (8%) samples. Tenascin C expression correlated with age (<= 66 v > 66 years) and poor differentiation (grades 1–2 v 3). There was no correlation between tenascin C expression and survival, clinical stage, tumour size, nodal status, distant metastasis, tumour location, or sex.

Conclusion: Tenascin C expression was increased in most pancreatic carcinomas, but contrary to the results in other cancers, it is not a prognostic factor in pancreatic cancer.

Abbreviations: CI, confidence interval; ECM, extracellular matrix; PBS, phosphate buffered saline

Keywords: pancreatic neoplasms; immunohistochemistry; tenascin C; prognosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs